Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brain

Parkinsonism and Related Disorders

Volumn 7, Issue 3, 2001, Pages 247-251

  Trojanowski, J Q ^a   Lee, V M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alpha synuclein; Beta synuclein; Gamma synuclein; Parkinson's disease; Synucleinopathies

Indexed keywords

SYNUCLEIN;

CONFERENCE PAPER; DEGENERATIVE DISEASE; HUMAN; IMMUNOLOGY; MISSENSE MUTATION; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE;

EID: 0035027982     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(00)00065-1     Document Type: Conference Paper

References (43)

1. Parkinson's disease
2. Synucleins in synaptic plasticity and neurodegenerative disorders
3. The cellular and molecular pathology of Parkinson's disease
4. Filamentous nerve cell inclusions in neurodegenerative diseases
5. Purification of Lewy bodies and identification of α-synuclein as a major component of Lewy bodies
6. Ala30-to-pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
7. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
8. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
9. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein
10. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes
11. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease
12. Alpha synuclein in neurodegenerative disorders: murderer or accomplice?
13. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
14. Alpha-synuclein in Lewy bodies
15. Abnormal distribution of the non-amyloid-beta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment
16. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders
17. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease
18. A panel of epitope specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease
19. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease
20. Synthetic filaments assembled from C-terminally truncated alpha-synuclein
21. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro
22. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro
23. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation
24. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop
25. Alpha-synuclein cortical Lewy bodies are markers for dementia in Parkinson's disease
26. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimers disease
27. Widespread alterations of alpha-synuclein in multiple system atrophy
28. Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury
29. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
30. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
31. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
32. Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components
33. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
34. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta- and gamma-synuclein
35. The expression of alpha-, beta- and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases
36. Neurofilament functions in health and disease
37. Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice
38. Formation of inclusion bodies and loss of dopaminergic nerve terminals in human alpha-synuclein transgenic mice: implications for neurodegenerative disorders
39. Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration
40. Alpha-synuclein - a link between Parkinson and Alzheimer diseases?
41. Failure to replicate a protective effect of allele 2 of NACP/alpha-synuclein polymorphism in Alzheimer's disease: an association study
42. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype
43. Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism